Overexpression of a Mr 110,000 Vesicular Protein in Non-P-Glycoprotein-mediated Multidrug Resistance RJ Scheper, HJ Broxterman, GL Scheffer, P Kaaijk, WS Dalton, ... Cancer research 53 (7), 1475-1479, 1993 | 828 | 1993 |
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave ERA Vos, G den Hartog, RM Schepp, P Kaaijk, J van Vliet, K Helm, ... J epidemiol community health 75 (6), 489-495, 2021 | 89 | 2021 |
In vitro and in vivo models for the study of brain tumour invasion. GJ Pilkington, R Bjerkvig, L De Ridder, P Kaaijk Anticancer research 17 (6B), 4107-4109, 1997 | 89 | 1997 |
Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoire R Bos, S Van Duikeren, T Van Hall, P Kaaijk, R Taubert, B Kyewski, ... Cancer research 65 (14), 6443-6449, 2005 | 72 | 2005 |
Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis B van de Waterbeemd, G Zomer, P Kaaijk, N Ruiterkamp, RH Wijffels, ... PloS one 8 (5), e65157, 2013 | 61 | 2013 |
Expression of CD44 splice variants in human primary brain tumors P Kaaijk, D Troost, F Morsink, RMJ Keehnen, S Leenstra, DA Bosch, ... Journal of neuro-oncology 26, 185-190, 1995 | 61 | 1995 |
Preclinical safety and immunogenicity evaluation of a nonavalent PorA native outer membrane vesicle vaccine against serogroup B meningococcal disease P Kaaijk, I van Straaten, B van de Waterbeemd, EPJ Boot, LMAR Levels, ... Vaccine 31 (7), 1065-1071, 2013 | 59 | 2013 |
Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? Experience from the Netherlands P Kaaijk, A van der Ende, G Berbers, GPJM van den Dobbelsteen, ... BMC Infectious Diseases 12, 1-6, 2012 | 57 | 2012 |
Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype P Kaaijk, BA van der Zeijst, MC Boog, CW Hoitink Eurosurveillance 13 (26), 18914, 2008 | 56 | 2008 |
Differential expression of CD44 splice variants in the normal human central nervous system P Kaaijk, ST Pals, F Morsink, DA Bosch, D Troost Journal of neuroimmunology 73 (1-2), 70-76, 1997 | 52 | 1997 |
Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations NY Rots, AJ Wijmenga-Monsuur, W Luytjes, P Kaaijk, TW De Graaf, ... Vaccine 28 (4), 893-900, 2010 | 48 | 2010 |
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia P Kaaijk, GJL Kaspers, ER Van Wering, GJ Broekema, AH Loonen, ... British journal of cancer 88 (5), 775-781, 2003 | 48 | 2003 |
Vaccination against RSV: is maternal vaccination a good alternative to other approaches? P Kaaijk, W Luytjes, NY Rots Human vaccines & immunotherapeutics 9 (6), 1263-1267, 2013 | 43 | 2013 |
Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection S Gouma, HI Ten Hulscher, TM Schurink-van’t Klooster, HE de Melker, ... Vaccine 34 (35), 4166-4171, 2016 | 41 | 2016 |
High concentration of daunorubicin and daunorubicinol in human malignant astrocytomas after systemic administration of liposomal daunorubicin KW Albrecht, PC de Witt Hamer, S Leenstra, PJM Bakker, JH Beijnen, ... Journal of neuro-oncology 53, 267-271, 2001 | 37* | 2001 |
Long‐term culture of organotypic multicellular glioma spheroids: a good culture model for studying gliomas P Kaaijk, D Troostt, PK Dast, S Leenstra, DA Bosch Neuropathology and applied neurobiology 21 (5), 386-391, 1995 | 36 | 1995 |
Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas P Kaaijk, D Troost, OJ De Boer, P Van Amstel, PJM Bakker, S Leenstra, ... British journal of cancer 74 (2), 187-193, 1996 | 35 | 1996 |
The National Immunisation Programme in the Netherlands: Surveillance and developments in 2017-2018 TM Schurink-van't Klooster, HE de Melker Rijksinstituut voor Volksgezondheid en Milieu RIVM, 2017 | 34 | 2017 |
In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical … D Bresters, AJF Broekhuizen, P Kaaijk, GT Faircloth, J Jimeno, ... Leukemia 17 (7), 1338-1343, 2003 | 33 | 2003 |
Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas P Kaaijk, D Troost, P Sminia, M Hulshof, AHW Van Der Kracht, S Leenstra, ... European Journal of Cancer 33 (4), 645-651, 1997 | 33 | 1997 |